Catalyst calendar
Data as of 2026-08-19 16:00 UTC · tracked universe polled every 15 minutes
Three kinds of date: a PDUFA date (the deadline the FDA sets itself to decide on a drug application), an AdCom (an FDA advisory-committee meeting that reviews it in public), and a readout window (when a trial's results are expected). Dates marked confirmed by the company come from an 8-K or press-release quote; our estimate is a rule-derived window off the trial's registered primary-completion date (see methodology) — never shown the same way. Today: 200 estimated readout windows and 0 disclosed PDUFA/AdCom dates.
Next 7 days
| Date | Ticker | Phase | Event |
|---|---|---|---|
| 2027-06-21 in 44w | $ITCI | Phase 3 | Multicenter Study of Lumateperone for the Treatment of Irritability Associated… NCT06706674 |
| 2027-06-23 in 44w | $BPMC | Phase 2 | (PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A… NCT03731260 |
| 2027-06-25 in 44w | $APLS | Phase 2 | A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to… NCT07215390 |
| 2027-06-30 in 45w | $ALNY | Phase 2 | HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female… NCT07575308 |
| 2027-06-30 in 45w | $AMGN | Phase 3 | A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism… NCT03969329 |
| 2027-06-30 in 45w | $VRTX | Phase 3 | A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type… NCT04786262 |
| 2027-06-30 in 45w | $AMGN | Phase 3 | A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab… NCT05920356 |
| 2027-07-01 in 45w | $VKTX | Phase 3 | VK2735 for Weight Management Phase 3 NCT07104500 |
| 2027-07-01 in 45w | $VKTX | Phase 3 | VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2) NCT07104383 |
| 2027-07-05 in 46w | $AMGN | Phase 3 | Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line… NCT06211036 |
| 2027-07-22 in 48w | $VRTX | Phase 2 | Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1… NCT07161037 |
| 2027-08-07 in 50w | $BIIB | Phase 3 | A Study of BIIB067 (Tofersen) Initiated in Clinically Presymptomatic Adults… NCT04856982 |
| 2027-08-09 in 51w | $ALNY | Phase 2 | A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy NCT06393712 |
| 2027-09-24 in 57w | $BIIB | Phase 3 | A Study to Learn About the Effect of Higher Doses of Nusinersen (BIIB058) Given… NCT05067790 |
| 2027-09-30 in 58w | $VRTX | Phase 3 | Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis… NCT06460506 |
| 2027-10-07 in 59w | $ARGX | Phase 3 | A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP NCT07091630 |
| 2027-10-14 in 60w | $ITCI | Phase 2 | Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety… NCT06701903 |
| 2027-11-14 in 65w | $VRTX | Phase 3 | Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With… NCT05356195 |
| 2027-11-16 in 65w | $BIIB | Phase 3 | A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone… NCT06953583 |
| 2027-12-27 in 71w | $ALNY | Phase 3 | TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in… NCT07223203 |
| 2027-12-28 in 71w | $ITCI | Phase 2 | A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of… NCT06651567 |
| 2027-12-31 in 71w | $PTCT | Phase 3 | A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With… NCT05515536 |
| 2028-01-26 in 75w | $REGN | Phase 2 | A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab… NCT05557591 |
| 2028-01-31 in 76w | $BIIB | Phase 2 | A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its… NCT07722546 |
| 2028-02-10 in 77w | $BIIB | Phase 2 | A Study to Learn About the Effects of Felzartamab Infusions in Adults With… NCT07219043 |